Casey Cummins

Home/Casey Cummins
About Casey Cummins

Casey Cummins, MSN, APRN, NP-C is a board-certified Family Nurse Practitioner who currently serves as the Chief Nurse Consultant for the Immunizations Division at the Indiana Department of Health. She is part of the ISDH COVID-19 Outbreak Response Team, and has assisted with coordinating testing efforts state-wide during the pandemic. She enjoys spending time with her husband and their children, being outdoors, gardening, and traveling whenever possible.

Multisystem Imaging Manifestations of COVID-19 In this article, authors discuss the effects of COVID-19 on multiple extrapulmonary systems. Widespread involvement of multiple body systems is attributed to the expression of ACE2 receptors in extrapulmonary tissues, resulting in direct tissue damage. Read More
Mitigation Measures in Delaware Lead to Decline in New COVID-19 Cases, Hospitalization, and Deaths In this Morbidity and Mortality Weekly Report, lab and case investigation studies investigated mitigation measures such as stay-at-home orders, public mask mandates, contact tracing and investigation, Read More
Cardiac Injury Prediction In COVID-19 Patients In this article from the International Journal of Cardiology, data from 124 consecutive hospitalized patients with COVID-19 were collected. The authors attempt to determine risk factors and predictive markers of cardiac injury in COVID-19 Read More
What Healthcare Professionals Need to Know about COVID-19 Vaccination Plans The CDC released this publication, which discusses “Operation Warp Speed”, the global race to produce a successful COVID-19 vaccination. With the likelihood of a vaccine being produced by the end Read More
Thromboprophylaxis treatment in critically ill COVID-19 patients In this article, a patient-tailored thromboprophylaxis protocol is discussed to reduce rates of venous and arterial thrombotic events related to COVID-19 in critically ill patients. Approximately 20-60% of critically ill COVID-19 patients have Read More
In-home testing kits for COVID-19 In this article, the authors discuss testing kits that have been FDA approved for diagnosing COVID-19 in the home. In April 2020, LabCorp developed the first FDA-approved, in-home collection kit, followed Everlywell who developed a Read More
Clinical characteristics and lab results to predict severity of infection In this retrospective study, authors attempt to identify early clinical and laboratory factors that may predict severe COVID-19 infection. Two cohorts were designed among 198 patients to designate those with Read More
RCT’s of therapeutic interventions against COVID-19 In this journal article, the authors discuss the challenges that plagued us during the early days of the COVID-19 pandemic. When the pandemic emerged, clinicians were faced with an unknown virus and had very Read More
COVID-19 effects on neurological conditions SARS-CoV-2 has been noted to have neurological complications. In this article, the authors discuss the underreporting of conditions such as postinfectious demyelination, encephalitis, seizures, and other neurotropic conditions that may be underreported complications of COVID-19. Read More
Updates to seasonal influenza vaccine practices during the COVID-19 pandemic The ACIP and CDC released this recommendation on August 21, 2020 that updates the 2019-2020 recommendations of the ACIP regarding the use of seasonal influenza vaccines in the U.S. As Read More

Get Involved with Indiana CTSI